Literature DB >> 23839048

FKBPs and the Akt/mTOR pathway.

Felix Hausch1, Christian Kozany, Marily Theodoropoulou, Anne-Katrin Fabian.   

Abstract

FK506-binding proteins (FKBP) belong to the immunophilin family and are best known for their ability to enable the immunosuppressive properties of FK506 and rapamycin. For rapamycin, this is achieved by inducing inhibitory ternary complexes with the kinase mTOR. The essential accessory protein for this gain-of-function was thought to be FKBP12. We recently showed that this view might be too restricted, since larger FK506-binding proteins can functionally substitute for FKBP12 in mammalian cells. Recent studies have also shown that FK506-binding proteins can modulate Akt-mTOR signaling in the absence of rapamycin. Here we discuss the role of FK506-binding proteins for the mechanism of rapamycin as well as their intrinsic actions on the Akt/mTOR pathway.

Entities:  

Keywords:  Akt; FK506 binding protein; FKBP; PKB; mTOR; rapamycin

Mesh:

Substances:

Year:  2013        PMID: 23839048      PMCID: PMC3841315          DOI: 10.4161/cc.25508

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  40 in total

1.  Comparative analysis of calcineurin inhibition by complexes of immunosuppressive drugs with human FK506 binding proteins.

Authors:  Matthias Weiwad; Frank Edlich; Susann Kilka; Frank Erdmann; Franziska Jarczowski; Madlen Dorn; Marie-Christine Moutty; Gunter Fischer
Journal:  Biochemistry       Date:  2006-12-19       Impact factor: 3.162

2.  Increasing the efficiency of ligands for FK506-binding protein 51 by conformational control.

Authors:  Yansong Wang; Alexander Kirschner; Anne-Katrin Fabian; Ranganath Gopalakrishnan; Christoph Kress; Bastiaan Hoogeland; Uwe Koch; Christian Kozany; Andreas Bracher; Felix Hausch
Journal:  J Med Chem       Date:  2013-05-06       Impact factor: 7.446

3.  Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

Authors:  Dos D Sarbassov; Siraj M Ali; Shomit Sengupta; Joon-Ho Sheen; Peggy P Hsu; Alex F Bagley; Andrew L Markhard; David M Sabatini
Journal:  Mol Cell       Date:  2006-04-06       Impact factor: 17.970

4.  Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38.

Authors:  Xiaochun Bai; Dongzhu Ma; Anling Liu; Xiaoyun Shen; Qiming J Wang; Yongjian Liu; Yu Jiang
Journal:  Science       Date:  2007-11-09       Impact factor: 47.728

5.  A gene atlas of the mouse and human protein-encoding transcriptomes.

Authors:  Andrew I Su; Tim Wiltshire; Serge Batalov; Hilmar Lapp; Keith A Ching; David Block; Jie Zhang; Richard Soden; Mimi Hayakawa; Gabriel Kreiman; Michael P Cooke; John R Walker; John B Hogenesch
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-09       Impact factor: 11.205

6.  Re-evaluating the roles of proposed modulators of mammalian target of rapamycin complex 1 (mTORC1) signaling.

Authors:  Xuemin Wang; Bruno D Fonseca; Hua Tang; Rui Liu; Androulla Elia; Michael J Clemens; Ulrich-Axel Bommer; Christopher G Proud
Journal:  J Biol Chem       Date:  2008-08-01       Impact factor: 5.157

Review 7.  Regulation of ryanodine receptors by FK506 binding proteins.

Authors:  Mihail G Chelu; Cristina I Danila; Charles P Gilman; Susan L Hamilton
Journal:  Trends Cardiovasc Med       Date:  2004-08       Impact factor: 6.677

8.  Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function.

Authors:  Noriko Oshiro; Ken-ichi Yoshino; Sujuti Hidayat; Chiharu Tokunaga; Kenta Hara; Satoshi Eguchi; Joseph Avruch; Kazuyoshi Yonezawa
Journal:  Genes Cells       Date:  2004-04       Impact factor: 1.891

9.  A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway.

Authors:  Tewis Bouwmeester; Angela Bauch; Heinz Ruffner; Pierre-Olivier Angrand; Giovanna Bergamini; Karen Croughton; Cristina Cruciat; Dirk Eberhard; Julien Gagneur; Sonja Ghidelli; Carsten Hopf; Bettina Huhse; Raffaella Mangano; Anne-Marie Michon; Markus Schirle; Judith Schlegl; Markus Schwab; Martin A Stein; Andreas Bauer; Georg Casari; Gerard Drewes; Anne-Claude Gavin; David B Jackson; Gerard Joberty; Gitte Neubauer; Jens Rick; Bernhard Kuster; Giulio Superti-Furga
Journal:  Nat Cell Biol       Date:  2004-01-25       Impact factor: 28.824

10.  The switch I region of Rheb is critical for its interaction with FKBP38.

Authors:  Dongzhu Ma; Xiaochun Bai; Shuguang Guo; Yu Jiang
Journal:  J Biol Chem       Date:  2008-07-25       Impact factor: 5.157

View more
  19 in total

1.  Spliced X-box Binding Protein 1 Stimulates Adaptive Growth Through Activation of mTOR.

Authors:  Xiaoding Wang; Yingfeng Deng; Guangyu Zhang; Chao Li; Guanqiao Ding; Herman I May; Diem H Tran; Xiang Luo; Ding-Sheng Jiang; Dan L Li; Xiang Wei; Lin Xu; Anwarul Ferdous; Thomas G Gillette; Philipp E Scherer; Xuejun Jiang; Zhao V Wang
Journal:  Circulation       Date:  2019-06-10       Impact factor: 29.690

2.  Selective inhibitors of the FK506-binding protein 51 by induced fit.

Authors:  Steffen Gaali; Alexander Kirschner; Serena Cuboni; Jakob Hartmann; Christian Kozany; Georgia Balsevich; Christian Namendorf; Paula Fernandez-Vizarra; Claudia Sippel; Anthony S Zannas; Rika Draenert; Elisabeth B Binder; Osborne F X Almeida; Gerd Rühter; Manfred Uhr; Mathias V Schmidt; Chadi Touma; Andreas Bracher; Felix Hausch
Journal:  Nat Chem Biol       Date:  2014-12-01       Impact factor: 15.040

3.  TPC2 polymorphisms associated with a hair pigmentation phenotype in humans result in gain of channel function by independent mechanisms.

Authors:  Yu-Kai Chao; Verena Schludi; Cheng-Chang Chen; Elisabeth Butz; O N Phuong Nguyen; Martin Müller; Jens Krüger; Claudia Kammerbauer; Manu Ben-Johny; Angelika M Vollmar; Carola Berking; Martin Biel; Christian A Wahl-Schott; Christian Grimm
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-18       Impact factor: 11.205

4.  Maternal lipodome across pregnancy is associated with the neonatal DNA methylome.

Authors:  Jennifer L LaBarre; Carolyn F McCabe; Tamara R Jones; Peter Xk Song; Steven E Domino; Marjorie C Treadwell; Dana C Dolinoy; Vasantha Padmanabhan; Charles F Burant; Jaclyn M Goodrich
Journal:  Epigenomics       Date:  2020-12-08       Impact factor: 4.778

Review 5.  Autophagy awakens-the myriad roles of autophagy in head and neck cancer development and therapeutic response.

Authors:  Samantha T Bradley; Yong-Syu Lee; Zafer Gurel; Randall J Kimple
Journal:  Mol Carcinog       Date:  2021-11-15       Impact factor: 4.784

6.  Effects of autophagy inducers on recombinant antibody production in insect cells.

Authors:  Ryou Nakanuma; Kyoko Masumi-Koizumi; Yuki Ohmuro-Matsuyama; Tomohisa Katsuda; Hideki Yamaji
Journal:  Cytotechnology       Date:  2020-09-29       Impact factor: 2.040

7.  FKBP51 employs both scaffold and isomerase functions to promote NF-κB activation in melanoma.

Authors:  Simona Romano; Yichuan Xiao; Mako Nakaya; Anna D'Angelillo; Mikyoung Chang; Jin Jin; Felix Hausch; Mariorosario Masullo; Xixi Feng; Maria Fiammetta Romano; Shao-Cong Sun
Journal:  Nucleic Acids Res       Date:  2015-06-22       Impact factor: 16.971

8.  Reversal of Aging-Related Neuronal Ca2+ Dysregulation and Cognitive Impairment by Delivery of a Transgene Encoding FK506-Binding Protein 12.6/1b to the Hippocampus.

Authors:  John C Gant; Kuey-Chu Chen; Inga Kadish; Eric M Blalock; Olivier Thibault; Nada M Porter; Philip W Landfield
Journal:  J Neurosci       Date:  2015-07-29       Impact factor: 6.167

9.  Brusatol Inhibits Tumor Growth and Increases the Efficacy of Cabergoline against Pituitary Adenomas.

Authors:  Zerui Wu; Yunqiu Xu; Jiadong Xu; Jianglong Lu; Lin Cai; Qun Li; Chengde Wang; Zhipeng Su
Journal:  Oxid Med Cell Longev       Date:  2021-06-16       Impact factor: 6.543

10.  Proximity-Directed Labeling Reveals a New Rapamycin-Induced Heterodimer of FKBP25 and FRB in Live Cells.

Authors:  Song-Yi Lee; Hakbong Lee; Hye-Kyeong Lee; Seung-Won Lee; Sung Chul Ha; Taejoon Kwon; Jeong Kon Seo; Changwook Lee; Hyun-Woo Rhee
Journal:  ACS Cent Sci       Date:  2016-08-12       Impact factor: 14.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.